{
  "symbol": "MESO",
  "socialMediaRisk": {
    "hypeSusceptibility": true,
    "volatilityDrivenBy": ["Biotechnology sector", "Small-cap company", "Phase III clinical trials"],
    "riskScore": 8,
    "reason": "Mesoblast operates in the biotech sector, which is prone to speculation, and is a small-cap company with products in clinical trials, making it susceptible to retail-driven volatility."
  }
}